NIPA1
Basic information
Region (hg38): 15:22773063-22829789
Previous symbols: [ "SPG6" ]
Links
Phenotypes
GenCC
Source:
- hereditary spastic paraplegia 6 (Moderate), mode of inheritance: AD
- hereditary spastic paraplegia 6 (Supportive), mode of inheritance: AD
- hereditary spastic paraplegia 6 (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Spastic paraplegia 6, autosomal dominant | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 7854534; 14508710; 15711826; 21419568; 21599812; 22302102 |
ClinVar
This is a list of variants' phenotypes submitted to
- Hereditary spastic paraplegia 6 (4 variants)
- Hereditary spastic paraplegia (1 variants)
- not provided (1 variants)
- Spastic paraplegia (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NIPA1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 45 | 50 | ||||
missense | 72 | 78 | ||||
nonsense | 0 | |||||
start loss | 1 | |||||
frameshift | 0 | |||||
inframe indel | 16 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 4 | 6 | |||
non coding | 80 | 29 | 57 | 166 | ||
Total | 4 | 0 | 165 | 81 | 61 |
Variants in NIPA1
This is a list of pathogenic ClinVar variants found in the NIPA1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-22786298-C-G | Benign (Jun 16, 2018) | |||
15-22786362-G-C | Likely benign (Jan 28, 2019) | |||
15-22786446-CG-C | Benign (Sep 20, 2019) | |||
15-22786638-G-A | Spastic paraplegia, autosomal dominant | Uncertain significance (Jun 14, 2016) | ||
15-22786647-C-G | NIPA1-related disorder | Likely benign (Jun 15, 2022) | ||
15-22786657-A-G | Hereditary spastic paraplegia 6 | Uncertain significance (Jan 12, 2018) | ||
15-22786662-G-C | Hereditary spastic paraplegia 6 | Likely benign (Sep 15, 2022) | ||
15-22786663-ACTGCAG-A | Hereditary spastic paraplegia 6 | Uncertain significance (Sep 26, 2023) | ||
15-22786664-C-T | Hereditary spastic paraplegia 6 | Uncertain significance (Oct 24, 2023) | ||
15-22786665-TGCAGCTGCG-T | Hereditary spastic paraplegia 6 | Uncertain significance (Jun 15, 2023) | ||
15-22786667-C-T | Hereditary spastic paraplegia | Uncertain significance (Dec 12, 2016) | ||
15-22786669-G-T | Uncertain significance (Dec 24, 2019) | |||
15-22786670-C-T | Hereditary spastic paraplegia 6 | Uncertain significance (Dec 30, 2023) | ||
15-22786671-TGCGGCA-T | Hereditary spastic paraplegia 6 • Hereditary spastic paraplegia | Conflicting classifications of pathogenicity (Oct 13, 2023) | ||
15-22786671-TGCGGCAGCG-T | Hereditary spastic paraplegia 6 | Uncertain significance (Oct 17, 2022) | ||
15-22786671-TGCGGCAGCGGCGGCG-T | Hereditary spastic paraplegia 6 | Uncertain significance (Jul 17, 2023) | ||
15-22786671-TGCGGCAGCGGCGGCGGCG-T | Hereditary spastic paraplegia 6 | Uncertain significance (Jan 21, 2023) | ||
15-22786671-TGCGGCAGCGGCGGCGGCGGCGGCGGCG-T | Hereditary spastic paraplegia 6 | Uncertain significance (Nov 07, 2023) | ||
15-22786671-T-TGCGGCA | Hereditary spastic paraplegia 6 | Benign (Aug 09, 2022) | ||
15-22786673-C-A | Hereditary spastic paraplegia 6 | Uncertain significance (Mar 16, 2018) | ||
15-22786673-C-G | not specified • Hereditary spastic paraplegia 6 | Conflicting classifications of pathogenicity (Dec 14, 2023) | ||
15-22786673-C-T | Hereditary spastic paraplegia 6 | Uncertain significance (Nov 27, 2023) | ||
15-22786674-GGCA-G | Hereditary spastic paraplegia 6 • Hereditary spastic paraplegia | Benign/Likely benign (Apr 07, 2023) | ||
15-22786675-G-A | Hereditary spastic paraplegia 6 | Uncertain significance (Aug 12, 2021) | ||
15-22786676-C-T | Hereditary spastic paraplegia 6 | Uncertain significance (Aug 10, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NIPA1 | protein_coding | protein_coding | ENST00000337435 | 5 | 56729 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00587 | 0.912 | 125738 | 0 | 9 | 125747 | 0.0000358 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.94 | 110 | 184 | 0.597 | 0.0000108 | 2073 |
Missense in Polyphen | 24 | 53.597 | 0.44779 | 601 | ||
Synonymous | -1.32 | 107 | 90.9 | 1.18 | 0.00000649 | 725 |
Loss of Function | 1.49 | 5 | 10.1 | 0.495 | 4.30e-7 | 125 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000578 | 0.0000578 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000264 | 0.0000264 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as a Mg(2+) transporter. Can also transport other divalent cations such as Fe(2+), Sr(2+), Ba(2+), Mn(2+) and Co(2+) but to a much less extent than Mg(2+) (By similarity). {ECO:0000250}.;
- Pathway
- Prader-Willi and Angelman Syndrome;Transport of small molecules;Miscellaneous transport and binding events
(Consensus)
Recessive Scores
- pRec
- 0.152
Intolerance Scores
- loftool
- 0.263
- rvis_EVS
- -0.32
- rvis_percentile_EVS
- 31.46
Haploinsufficiency Scores
- pHI
- 0.424
- hipred
- Y
- hipred_score
- 0.607
- ghis
- 0.610
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.162
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Nipa1
- Phenotype
- homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- magnesium ion transport;transmembrane transport;magnesium ion transmembrane transport
- Cellular component
- early endosome;plasma membrane;integral component of membrane
- Molecular function
- magnesium ion transmembrane transporter activity